当前位置:药药网 / 数据中心 / 生物制药海外临床研究状况
A Study of Ustekinumab in Pediatric Participants With Moderately to Severely Active Ulcerative Colitis (UC)
标题(英文)
A Study of Ustekinumab in Pediatric Participants With Moderately to Severely Active Ulcerative Colitis (UC)
干预
Drug: Ustekinumab Dose Based on BSA and Body Weight|Drug: Matching Placebo